Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth
Authors
Keywords
Vascular targeting, TNFα, IFNγ, Colorectal cancer, Drug delivery
Journal
Journal of Translational Medicine
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-26
DOI
10.1186/s12967-016-0944-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular-targeted TNFα improves tumor blood vessel function and enhances antitumor immunity and chemotherapy in colorectal cancer
- (2015) Lan Lu et al. JOURNAL OF CONTROLLED RELEASE
- Targeted drug delivery for cancer therapy: the other side of antibodies
- (2012) Michael A Firer et al. Journal of Hematology & Oncology
- Selective Targeting of Interferon to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
- (2012) R. Bansal et al. MOLECULAR CANCER THERAPEUTICS
- Tumor-targeted TNF stabilizes tumor vessels and enhances active immunotherapy
- (2012) A. Johansson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy
- (2011) E. Dondossola et al. CANCER RESEARCH
- Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
- (2011) V. Gregorc et al. CLINICAL CANCER RESEARCH
- Vandetanib Improves Anti-Tumor Effects of L19mTNF in Xenograft Models of Esophageal Cancer
- (2010) M. Crescenzi et al. CLINICAL CANCER RESEARCH
- Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy
- (2010) Armando Santoro et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery
- (2010) Zhi Jie Li et al. JOURNAL OF CONTROLLED RELEASE
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- Targeted therapy of renal cell carcinoma: Synergistic activity of cG250-TNF and IFNg
- (2009) Stefan Bauer et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Tumor vasculature-targeted delivery of tumor necrosis factor-α*
- (2008) Anita Tandle et al. CANCER
- Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC
- (2008) Xiaoli Hui et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Delivery of Murine IFN-γ Using a Recombinant Fowlpox Virus: NK Cell Recruitment to Regional Lymph Nodes and Priming of Tumor-Specific Host Immunity
- (2008) Hasan Zeytin et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer
- (2008) Maria T.S. Bertilaccio et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started